UltraHuman raises $35m Series B

Investors were: Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will deploy the funds towards building further manufacturing capacity and deeper research in the health tracking space.

The company has developed a smart ring called Ring Air (pictured) a continuous glucose monitoring wearable called M1 Live, a home health device called Ultrahuman Home and a preventive blood testing product called Blood Vision. The company’s platform integrates glucose, sleep, movement, blood markers, and HRV The company has 150 retail outlets worldwide, including Selfridges, Changi airport and the Virgin megastore in Dubai. “Shipping a new firmware version every 2 weeks and weekly app improvements reflect our commitment to excellence,” says CEO Mohit Kumar. Ultrahuman is on track to surpass $100 million in profitable annualised revenue run rate by the end of 2024. UltraFactory, the company’s manufacturing facility, is capable of supporting $200 million in annual revenue.